{"id":"W4386305115","doi":"10.1161/atvbaha.123.318781","title":"New Therapeutic Targets for the Prevention and Treatment of Venous Thromboembolism With a Focus on Factor XI Inhibitors","year":2023,"lang":"en","type":"review","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute","funders":"Servier; Canadian Institutes of Health Research; Regeneron Pharmaceuticals; Heart and Stroke Foundation of Canada; Alnylam Pharmaceuticals; Alexion Pharmaceuticals; Daiichi Sankyo Europe; Bristol-Myers Squibb","keywords":"Venous thromboembolism; Medicine; Intensive care medicine; Thrombosis; Surgery","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003896211,0.0005675905,0.0008288141,0.001829349,0.0002300531,0.0007429254,0.0004755743,0.0007942818,0.004817322],"category_scores_gemma":[0.0005419161,0.0001376159,0.0004792881,0.001207738,0.0002890313,0.0009211527,0.0004453379,0.00184939,0.00182486],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003631562,"about_ca_system_score_gemma":0.000784309,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005388688,"about_ca_topic_score_gemma":0.00108466,"domain_scores_codex":[0.9998463,0.00002823174,0.00002272991,0.00002108618,0.00006557276,0.00001596019],"domain_scores_gemma":[0.9998006,0.00009343174,0.00002679858,0.000006061607,0.0000537055,0.00001938157],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006824624,0.00009896492,0.0001466396,0.01637637,0.0001116692,0.0002899947,0.00005926114,0.0002943724,0.002804796,0.005018799,0.04283084,0.9318999],"study_design_scores_gemma":[0.00002021335,0.00009449234,0.0006585669,0.003785193,0.0001169853,0.001585859,0.00004154249,0.00008089831,0.0004159755,0.001703142,0.9914848,0.00001238731],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001306234,0.9976411,0.0001739542,0.0003871117,0.0003144642,0.000006335053,0.00002024477,0.00000973138,0.001316534],"genre_scores_gemma":[0.0006192248,0.9979002,0.0002245695,0.000277977,0.0002364476,0.000006500991,0.00003440224,0.000001596927,0.0006990244],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004817322,"threshold_uncertainty_score":0.01611561,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1140312615629581,"score_gpt":0.355640860388915,"score_spread":0.2416095988259569,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}